Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
PUT
Skyworks Solutions
SWKS
$10.6B
| $1.44M | ﹤0.01% |
+7,500
| New | +$1.33M |
|
2402
Edgewell Personal Care
EPC
$1.31B
| $1.44M | ﹤0.01% |
32,722
-50,368
| -61% | -$2.13M |
|
|
ICPT
2403
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.44M | ﹤0.01% |
71,874
-28,992
| -29% | -$575K |
|
2404
Coca-Cola Consolidated
COKE
$12.8B
| $1.43M | ﹤0.01% |
35,650
-28,820
| -45% | -$1.02M |
|
2405
Sarepta Therapeutics
SRPT
$1.77B
| $1.43M | ﹤0.01% |
18,394
-35,492
| -66% | -$2.69M |
|
2406
Camden National
CAC
$976M
| $1.43M | ﹤0.01% |
29,916
-5,924
| -17% | -$282K |
|
2407
Methode Electronics
MEI
$592M
| $1.43M | ﹤0.01% |
29,020
-43,258
| -60% | -$2.02M |
|
2408
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $1.43M | ﹤0.01% |
27,758
| – | – |
|
2409
Community Health Systems
CYH
$423M
| $1.43M | ﹤0.01% |
92,365
-193,500
| -68% | -$2.63M |
|
2410
ESCO Technologies
ESE
$7.92B
| $1.43M | ﹤0.01% |
15,211
-23,037
| -60% | -$2.32M |
|
2411
PUT
Cheniere Energy
LNG
$52.9B
| $1.42M | ﹤0.01% |
+16,400
| New | +$1.33M |
|
2412
Celsius Holdings
CELH
$7.03B
| $1.42M | ﹤0.01% |
56,082
-129,054
| -70% | -$2.63M |
|
|
SGMO
2413
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.42M | ﹤0.01% |
118,744
-132,243
| -53% | -$1.5M |
|
2414
Myriad Genetics
MYGN
$312M
| $1.41M | ﹤0.01% |
46,048
-47,437
| -51% | -$1.37M |
|
2415
Patterson-UTI
PTEN
$3.76B
| $1.41M | ﹤0.01% |
141,541
-220,340
| -61% | -$1.86M |
|
2416
Gray Television
GTN
$552M
| $1.41M | ﹤0.01% |
60,122
-66,337
| -52% | -$1.44M |
|
2417
PUT
eBay
EBAY
$49.8B
| $1.4M | ﹤0.01% |
20,000
| – | – |
|
2418
CALL
Willis Towers Watson
WTW
$32B
| $1.4M | ﹤0.01% |
6,100
| – | – |
|
|
2419
PUT
Willis Towers Watson
WTW
$32B
| $1.4M | ﹤0.01% |
6,100
| – | – |
|
|
DEA
2420
Easterly Government Properties
DEA
$1.18B
| $1.4M | ﹤0.01% |
26,631
-42,260
| -61% | -$2.23M |
|
2421
CALL
Kohl's
KSS
$2.19B
| $1.4M | ﹤0.01% |
25,400
| – | – |
|
2422
Shenandoah Telecom
SHEN
$746M
| $1.4M | ﹤0.01% |
28,816
-32,793
| -53% | -$1.62M |
|
2423
TORM
TRMD
$3.02B
| $1.4M | ﹤0.01% |
158,735
+155,062
| +4,222% | +$1.4M |
|
2424
British American Tobacco
BTI
$128B
| $1.39M | ﹤0.01% |
35,410
+14,512
| +69% | +$568K |
|
2425
CALL
Vistra
VST
$47.4B
| $1.39M | ﹤0.01% |
+75,000
| New | +$1.29M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.